Valganciclovir: A new oral alternative for cytomegalovirus retinitis in human immunodeficiency virus-seropositive individuals.
about
Valganciclovir in the treatment of cytomegalovirus retinitis in HIV-infected patients.A review of antiviral drugs and other compounds with activity against feline herpesvirus type 1Cytomegalovirus retinitis in Good syndrome: case report and review of literatureSuccessful oral valganciclovir treatment of cytomegalovirus infection during Campath-1H therapy.
P2860
Valganciclovir: A new oral alternative for cytomegalovirus retinitis in human immunodeficiency virus-seropositive individuals.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Valganciclovir: A new oral alt ...... irus-seropositive individuals.
@ast
Valganciclovir: A new oral alt ...... irus-seropositive individuals.
@en
Valganciclovir: A new oral alt ...... irus-seropositive individuals.
@nl
type
label
Valganciclovir: A new oral alt ...... irus-seropositive individuals.
@ast
Valganciclovir: A new oral alt ...... irus-seropositive individuals.
@en
Valganciclovir: A new oral alt ...... irus-seropositive individuals.
@nl
prefLabel
Valganciclovir: A new oral alt ...... irus-seropositive individuals.
@ast
Valganciclovir: A new oral alt ...... irus-seropositive individuals.
@en
Valganciclovir: A new oral alt ...... irus-seropositive individuals.
@nl
P2860
P1433
P1476
Valganciclovir: A new oral alt ...... irus-seropositive individuals.
@en
P2093
Marisel Segarra-Newnham
Martha I Salazar
P2860
P304
P356
10.1592/PHCO.22.13.1124.33527
P407
P577
2002-09-01T00:00:00Z